Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Scientific Reports|August 21, 2019
Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancyRatna Veeramachaneni, Thomas Walker, Timothée Revil, et al.
Histopathology|July 26, 2022
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancerAyaka Katayama, Jane Starczynski, Michael S Toss, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
Breast Cancer Research and Treatment|September 25, 2014
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cellsAleksandra Filipović, Ylenia Lombardo, Monica Faronato, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
Regulation of p53 tetramerization and nuclear export by ARCRoger S-Y Foo, Young-Jae Nam, Marc Jason Ostreicher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Lancet (London, England)|May 19, 2009
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trialPaul Ellis, Peter Barrett-Lee, Lindsay Johnson, et al.
Nature Communications|September 14, 2021
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulationRajbir Nath Batra, Aviezer Lifshitz, Ana Tufegdzic Vidakovic, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
Pageof 10